Prevalence and time course of acute mountain sickness in older children and adolescents after rapid ascent to 3450 meters

Détails

ID Serval
serval:BIB_D2E489B7CBD1
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Prevalence and time course of acute mountain sickness in older children and adolescents after rapid ascent to 3450 meters
Périodique
Pediatrics
Auteur⸱e⸱s
Bloch J., Duplain H., Rimoldi S.F., Stuber T., Kriemler S., Allemann Y., Sartori C., Scherrer U.
ISSN
1098-4275
Statut éditorial
Publié
Date de publication
2009
Peer-reviewed
Oui
Volume
123
Numéro
1
Pages
1-5
Langue
anglais
Résumé
OBJECTIVE: Acute mountain sickness is a frequent and debilitating complication of high-altitude exposure, but there is little information on the prevalence and time course of acute mountain sickness in children and adolescents after rapid ascent by mechanical transportation to 3500 m, an altitude at which major tourist destinations are located throughout the world. METHODS: We performed serial assessments of acute mountain sickness (Lake Louise scores) in 48 healthy nonacclimatized children and adolescents (mean +/- SD age: 13.7 +/- 0.3 years; 20 girls and 28 boys), with no previous high-altitude experience, 6, 18, and 42 hours after arrival at the Jungfraujoch high-altitude research station (3450 m), which was reached through a 2.5-hour train ascent. RESULTS: We found that the overall prevalence of acute mountain sickness during the first 3 days at high altitude was 37.5%. Rates were similar for the 2 genders and decreased progressively during the stay (25% at 6 hours, 21% at 18 hours, and 8% at 42 hours). None of the subjects needed to be evacuated to lower altitude. Five subjects needed symptomatic treatment and responded well. CONCLUSION: After rapid ascent to high altitude, the prevalence of acute mountain sickness in children and adolescents was relatively low; the clinical manifestations were benign and resolved rapidly. These findings suggest that, for the majority of healthy nonacclimatized children and adolescents, travel to 3500 m is safe and pharmacologic prophylaxis for acute mountain sickness is not needed.
Mots-clé
Acute Disease, Adolescent, Age Factors, Altitude, Altitude Sickness, Child, Female, Humans, Male, Mountaineering, Prevalence, Time Factors
Pubmed
Web of science
Open Access
Oui
Création de la notice
09/03/2009 12:59
Dernière modification de la notice
20/08/2019 16:52
Données d'usage